新天药业：欣力康胶囊获准开展用于癌因性疲乏治疗临床试验

Core Viewpoint - The company has received approval from the National Medical Products Administration for clinical trials of Xinlikang capsules, aimed at treating cancer-related fatigue [1] Group 1 - The approval allows the company to conduct clinical trials for Xinlikang capsules [1] - The indication for the clinical trial is specifically for the treatment of cancer-related fatigue [1]